News
The FDA clears GL-IL2-138, a groundbreaking oral drug modulating natural IL-2, set to revolutionize treatment in oncology.
The National Cancer Center Research Institute in Tokyo reports that a newly isolated gut bacterium, designated ...
From eating a healthy diet to minimising stress, here are a few ways to boost immunity, to ward off infections.
18h
Best Life on MSNScientists Find Shocking Link Between COVID and Alzheimer’sThe brain fog that can linger after a bout with COVID is not a new discovery. In fact, much research has linked this long-COVID symptom to the neuroinflammation that often accompanies an infection.
12h
HealthDay on MSNMany Ineligible for Clinical Trial Could Benefit From Teclistamab for Multiple MyelomaIn a study published online July 9 in Blood Cancer Discovery, real-world outcomes are described for teclistamab, a ...
During a live event, Jorge Monge, MD, discussed short and long-term adverse events associated with CAR T-cell therapy in ...
Researchers sought to determine whether dual-targeted CAR-T therapy would be effective for patients with relapsed or refractory MCL.
Detailed price information for Oncolytics Biotech Inc (ONCY-Q) from The Globe and Mail including charting and trades.
Genetic Leap, a clinical stage, AI-native biotech pioneering RNA genetic therapeutics, announced today that the U.S. Food and Drug Administration (FDA) has cleared its Investigational New Drug (IND) ...
The amended dosing regimen was approved based on results from a post hoc analysis of the phase 2 MagnetisMM-3 trial.
6h
The Brighterside of News on MSNAntibody spray breakthrough could prevent hay fever and asthmaA new scientific discovery is offering a promising breakthrough for people struggling with hay fever and asthma triggered by pollen. Scientists have found a way to stop allergic reactions caused by ...
Amino acids play a fundamental role in regulating how cells respond to drugs. These molecules, which form proteins, act like ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results